GlobalData on MSN13 天
EC approves GSK’s Menveo vaccine presentation for IMD
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
GlobalData on MSN1 天
FDA to review GSK’s Nucala for COPD
The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...
PMLiVE12 天
GSK granted EC approval for meningococcal disease vaccine Menveo
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
Daily13 天
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
【葛兰素史克的液体脑膜炎疫苗获欧盟批准】
【葛兰素史克的液体脑膜炎疫苗获欧盟批准】葛兰素史克(GSK)的液体脑膜炎疫苗Menveo已获得欧盟委员会的批准，可在欧盟销售。这家英国制药公司周三表示，这种全液体疫苗有助于简化针对侵袭性脑膜炎球菌病(IMD)的疫苗接种流程，因为它为医疗健康提供者提供了一种无需在使用前进行复溶的选择。
Pharmabiz13 天
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...
Nasdaq13 天
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...